| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/21/2005 | US20050085508 Gastrointestinal disorders; antiemetic agents; irritable bowel disorders; antipruritic agents |
| 04/21/2005 | US20050085505 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23 |
| 04/21/2005 | US20050085487 Heterocyclic compounds |
| 04/21/2005 | US20050085456 Compounds useful in therapy |
| 04/21/2005 | US20050085444 Cosmetic or dermatological use of vitamin a or the esters thereof in combination with a partly methylated beta-cyclodextrin |
| 04/21/2005 | US20050084534 Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
| 04/21/2005 | US20050084518 For producing beautiful skin and improving constipation, reducing hair loss |
| 04/21/2005 | US20050084505 Utilization of ubiquinones for influencing the effect of histamine |
| 04/21/2005 | US20050084489 Synergistic administration of Vitaxin, a FAB fragment, or a competitive binding antibody for binding integrin alpha V beta 3 with the enzyme inhibitor; antiinflammatory, anticarcinogenic agents; autoimmune and metabolic bone disorders |
| 04/21/2005 | US20050084486 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 04/21/2005 | US20050084484 Administering Lactobacillus plantarum having catalase activity and superoxide dismutase activity as an antiinflammatory agent for rheumatic diseases and psoriasis |
| 04/21/2005 | US20050084463 Antiinflammatory, antiarthritic agents, analgesics for pain caused by diabetic assoicated conditions, pneumoconiosis, angina, menstruation or cancer |
| 04/21/2005 | CA2539868A1 A method of healing skin wounds in mammals and a composition therefor |
| 04/21/2005 | CA2538093A1 Porifera-based therapeutic compositions for treating and preventing skin diseases |
| 04/21/2005 | CA2537473A1 Cytokine involved in epithelial-mesenchymal transition |
| 04/21/2005 | CA2537315A1 Protein biomaterials and biocoacervates and methods of making and using thereof |
| 04/20/2005 | EP1523997A1 A medical dressing comprising an antimicrobial silver compound |
| 04/20/2005 | EP1523982A2 Plenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 04/20/2005 | EP1523556A1 Methods of treating conditions associated with an edg-1 receptor |
| 04/20/2005 | EP1523488A1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
| 04/20/2005 | EP1523473A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 04/20/2005 | EP1523471A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 04/20/2005 | EP1523465A1 An hydroxytyrosol-rich composition from olive vegetation water and method of use thereof |
| 04/20/2005 | EP1523325A2 Methods and compositions for treating polycystic ovary syndrome |
| 04/20/2005 | EP1523316A2 Combination comprising an hmg-coa reductase inhibitor and an insulin secretor enhancer or an insulin sensitizer |
| 04/20/2005 | EP1373249B1 Imidazolidine derivatives, their preparation, and their use as antiinflamatory agent |
| 04/20/2005 | EP1357951B1 A medical dressing comprising an antimicrobial silver compound |
| 04/20/2005 | EP1318829B1 Angiogenic tri- or tetrapeptides derived from AcSDKP |
| 04/20/2005 | EP1307425B1 Novel n-(2-phenyl-3-aminopropyl)naphtamides |
| 04/20/2005 | EP1252158B1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 04/20/2005 | EP1226110B1 Bicyclic amino acids as pharmaceutical agents |
| 04/20/2005 | EP1177185B1 4, 5, 6, 7-tetrahydroindazole derivatives as antitumor agents |
| 04/20/2005 | EP1165495B1 Resorcinol derivatives |
| 04/20/2005 | EP1129077B1 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors |
| 04/20/2005 | EP1079853B1 Tuber or root derived protease inhibitors for preventing or treating inflammation or pruritis |
| 04/20/2005 | EP1059911B1 Formulations with an anti-viral effect |
| 04/20/2005 | EP0954278B1 Pharmaceutical compositions containing kukui nut oil |
| 04/20/2005 | EP0949919B1 A process for stabilizing levogyre ascorbic acid (laa) and stable laa compositions |
| 04/20/2005 | EP0805859B1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses |
| 04/20/2005 | CN2693232Y Medicinal plaster for treating keloid |
| 04/20/2005 | CN1608069A Selective androgen receptor modulators and methods for their identification, design and use |
| 04/20/2005 | CN1608067A Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 04/20/2005 | CN1608062A Salt forms of e-2-methoxy-n-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
| 04/20/2005 | CN1608055A Compounds for the treatment of metabolic disorders |
| 04/20/2005 | CN1608053A Heterocyclic derivatives of glycinamide and its pharmaceutical uses |
| 04/20/2005 | CN1607960A Glycoprotein compositions |
| 04/20/2005 | CN1607959A Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells |
| 04/20/2005 | CN1607956A Topical cosmetic composition having a natural plant active ingredient and method of using same |
| 04/20/2005 | CN1607946A Dermatological/cosmetic gels comprising at least one retinoid and benzoyl peroxide |
| 04/20/2005 | CN1607932A Methods for improving the aesthetic appearance of skin |
| 04/20/2005 | CN1607005A Soluble lymphotoxin- beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| 04/20/2005 | CN1606998A Chinese medicinal formulation for treating burn |
| 04/20/2005 | CN1606991A Externally applied medicine for treating beriberi and sweaty feet |
| 04/20/2005 | CN1197867C Application of cinidium general coumarin as psoriasis treating medicine |
| 04/20/2005 | CN1197849C 2, 3, 4, 5-tetrahydro-1H-[1, 4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 04/20/2005 | CN1197839C Stibene derivative organic amine salt, its preparation method, use and medicinal composition |
| 04/20/2005 | CN1197617C Fish serine proteinases and their pharmaceutical and cosmetic use |
| 04/20/2005 | CN1197605C Ointment for treating burns and scalds |
| 04/20/2005 | CN1197604C Ointment for treating burns and scalds, sore, bone tuberculosis and wounds |
| 04/20/2005 | CN1197595C Chinese medicine preparation for broad-spectrum inflammation relieving, disinfecting, erosion prevention and muscle growing |
| 04/20/2005 | CN1197589C Sore ulcer treating ointment and its prepn. |
| 04/20/2005 | CN1197588C Externally applied agent for treating skin suppuration infection |
| 04/19/2005 | US6881857 Tricyclic diterpene derivatives |
| 04/19/2005 | US6881776 Two-phase gel compositions obtained by mixing a gelled ester, ether, alcohol, natural fats or oils, triblock copolymers, star polymers, radial polymers, multi-block copolymers; and a hydrophobic, nonpolar solvent. |
| 04/19/2005 | US6881756 Method for treating skin disorders |
| 04/19/2005 | US6881755 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 04/19/2005 | US6881754 Adamantane derivatives |
| 04/19/2005 | US6881748 Drug targeting |
| 04/19/2005 | US6881730 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
| 04/19/2005 | US6881726 Aqueous compositions containing metronidazole |
| 04/19/2005 | US6881427 Topical anti-inflammatory composition containing linseed and licorice extracts |
| 04/19/2005 | US6881415 Emulsifier-free finely dispersed water-in-oil type systems |
| 04/19/2005 | US6881406 Administering an effective amount of a Chemokine receptor (CCR4) modulating agent, in a dose effective to modulate trafficking of systemic memmory T cells |
| 04/19/2005 | US6881399 Cosmetic formulations of having high aqueous solubility and low flash points |
| 04/19/2005 | CA2315189C Integrin receptor antagonists |
| 04/14/2005 | WO2005033302A1 Method of preparing hair papilla cell preparation, composition and method for regenerating hair follicle and animal having regenerated hair follicle |
| 04/14/2005 | WO2005033123A1 Stable vitamin b6 derivative |
| 04/14/2005 | WO2005033109A1 Triazinoindolamine compound |
| 04/14/2005 | WO2005033104A1 Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas |
| 04/14/2005 | WO2005032571A2 Method for the production of a medicinal tincture from higher mushrooms, medicinal tincture and use thereof |
| 04/14/2005 | WO2005032557A1 Mycocide composition |
| 04/14/2005 | WO2005032532A1 Antimycotic composition |
| 04/14/2005 | WO2005032531A1 Antimycotic composition |
| 04/14/2005 | WO2005032530A1 Pharmaceutical composition for external application |
| 04/14/2005 | WO2005032522A1 Topical aerosol foams |
| 04/14/2005 | WO2005009938A3 Dibenzoilmethane derivative compounds, the use thereof in the form of photoactivable solar filters and cosmetic compositions containing said compounds |
| 04/14/2005 | WO2004096216A3 Use of a topical medicament comprising riluzole |
| 04/14/2005 | WO2004092215A3 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 04/14/2005 | WO2003051287A3 Topical compositions and methods for treatment of adverse effects of ionizing radiation |
| 04/14/2005 | US20050080129 Derivatives of andrimide and moiramide b having antibacterial properties |
| 04/14/2005 | US20050080119 Diaminopropionic acid derivatives |
| 04/14/2005 | US20050080117 Substituted benzoxazoles as estrogenic agents |
| 04/14/2005 | US20050080107 Inhibitor of phosphodiesterase enzyme, 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid monohydrate; treating inflammatory diseases, diabetics, allergic diseases, autoimmune diseases, ocular diseases, osteoporosis, Parkinson's disease, dementia; chemical intermediates |
| 04/14/2005 | US20050080097 5-[1-(hydroxymethyl)propyl]amino-7-benzylamino-3-isopropyl(methyl, ethyl)pyrazolo[4,3-d]pyrimidine for inhibiting cell proliferation, cancer, or psoriasis, rheumatoid arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, graft rejection, and neurodegerative diseases |
| 04/14/2005 | US20050080067 Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 04/14/2005 | US20050080058 New vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments |
| 04/14/2005 | US20050080049 Applying a composition of phospholipid complexes of standardized extract of Vitis vinifera, phospholipid complexes of standardized extract of Centella asiatica, excipients, and carriers; antiwrinkling agent |
| 04/14/2005 | US20050080016 Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 04/14/2005 | US20050079572 Expression vector comprising nuclelotide sequences coding brain acid soluble protein 1 (BASP1) for use in prevention and treatment of infection, cell proliferative, inflammatory and autoimmune disorders; gene therapy; immunotherapeutics |
| 04/14/2005 | US20050079176 Treating stress response with chemokine receptor ccr5 modulators |